Reed Smith LLP | USA | 25 May 2023
For several years, we have blogged about the controversy over whether the American Law Institute (“ALI”) should put its Restatement Third of Torts…
Reed Smith LLP | USA | 15 May 2023
Each of these cases is significant enough to merit its own post, but since they came down within a week of each other, we’re discussing both of them…
Reed Smith LLP | USA | 7 May 2023
Some things make sense only in the topsy-turvy, litigate-everything-to-death world of Multidistrict Litigation. One recent example is In re Taxotere…
Reed Smith LLP | USA | 1 May 2023
One key point where implied preemption differs from express preemption is that express preemption is inherently limited by the language of the…
Reed Smith LLP | USA | 24 Apr 2023
Arbitration, if done right, is an effective, speedy, and low-cost alternative to civil litigation of all kinds, which is why the other side (or at…
Reed Smith LLP | USA | 17 Apr 2023
At least try to do something different. As we discussed before, because his prescription drug warning claims collided with federal preemption, the…
Reed Smith LLP | USA | 13 Apr 2023
Quick - when's the last time that a Federal Court of Appeals certified a pro-plaintiff ruling to the relevant state supreme court? We don't remember…
Reed Smith LLP | USA | 11 Apr 2023
When we last visited the Zostavax MDL last December, over a thousand plaintiffs, all claiming shingles as an injury, had been dismissed because none…
Reed Smith LLP | USA | 10 Apr 2023
One of the most fundamental limitations on tort liability - all tort liability - is that a plaintiff must suffer an injury before s/he can bring a…
Reed Smith LLP | USA | 31 Mar 2023
Time and time again, we have opposed efforts by one side of a scientific dispute - typically involving a prescription medical product - to attempt to…